IL17A and type 1 diabetes mellitus: In contrast, Espes et al. observed that long-term T1D patients who retained some β-cell function had higher circulating IL-35 and a greater abundance of IL-35+ regulatory cells, alongside lower levels of pathogenic IL-17a+ cells [152].